1. Interval between last chemotherapy and death |
1. Interval between last chemotherapy and death |
2. Site of death |
2. Site of death |
3. Frequency of ER visits |
3. Frequency of ER visits |
4.1. Hospital days near the end of life |
4.1. Hospital days near the end of life |
4.2. ICU days near the end of life |
4.2. ICU days near the end of life |
5. Continuity of care |
5. Continuity of care |
6. Time and location of care |
6. Time and location of care |
7. Adverse events |
7. Adverse events |
Partially measurable quality indicators |
8. Enrollment in palliative care near death |
|
9. Access to palliative care |
|
10. Radiotherapy for uncontrolled bone pain for bony metastases |
|
11. Potent antiemetic for emetogenic chemotherapy |
11. Potent antiemetic for emetogenic chemotherapy |
12. Multidisciplinary care |
12. Multidisciplinary care |
13. Access to care |
13. Access to care |
14. Interval between new chemotherapy and death |
|
Not currently measurable quality indicators |
|
8. Enrollment in palliative care near death |
|
9. Access to palliative care |
|
10. Radiotherapy for uncontrolled bone pain for bony metastases |
|
14. Interval between new chemotherapy and death |
15. Community-centred services |
15. Community-centred services |
16. Reimbursement |
16. Reimbursement |
17. Advance care directives |
17. Advance care directives |
18. Assessment of financial/care-giving resources |
18. Assessment of financial/care-giving resources |
19. Regular palliative care |
19. Regular palliative care |